Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day
1
item.page.dc.date.issued
2022-12-01
item.page.dc.type
item.page.dc.identifier.issn
15387933
item.page.dc.identifier.eissn
15387836
item.page.dc.identifier.doi
item.page.dc.identifier.scopus
2-s2.0-85140241213
item.page.dc.identifier.pmid
36201366
item.page.oaire.citation.title
Journal of Thrombosis and Haemostasis
item.page.oaire.citation.volume
20
item.page.oaire.citation.issue
12
item.page.oaire.citation.startPage
2964
item.page.oaire.citation.endPage
2971
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Journal of Thrombosis and Haemostasis Vol.20 No.12 (2022) , 2964-2971
punsarn.item.page.citation
Potere N., Barco S., Mahé I., Cesarman-Maus G., Angchaisuksiri P., Leader A., Okoye H.C., Olayemi E., Ay C., Carrier M., Connors J.M., Farmakis I.T., Fumagalli R.M., Jing Z.C., Lee L.H., McLintock C., Ní Ainle F., Giannakoulas G., Goto S., Guillermo Esposito M.C., Jara-Palomares L., Szlaszynska M., Tan C.W., Van Es N., Wang T.F., Hunt B.J., Di Nisio M. Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day. Journal of Thrombosis and Haemostasis Vol.20 No.12 (2022) , 2964-2971. 2971. doi:10.1111/jth.15902 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/85243
item.page.dc.title
Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day
item.page.dc.contributor.author
Potere N.
Barco S.
Mahé I.
Cesarman-Maus G.
Angchaisuksiri P.
Leader A.
Okoye H.C.
Olayemi E.
Ay C.
Carrier M.
Connors J.M.
Farmakis I.T.
Fumagalli R.M.
Jing Z.C.
Lee L.H.
McLintock C.
Ní Ainle F.
Giannakoulas G.
Goto S.
Guillermo Esposito M.C.
Jara-Palomares L.
Szlaszynska M.
Tan C.W.
Van Es N.
Wang T.F.
Hunt B.J.
Di Nisio M.
Barco S.
Mahé I.
Cesarman-Maus G.
Angchaisuksiri P.
Leader A.
Okoye H.C.
Olayemi E.
Ay C.
Carrier M.
Connors J.M.
Farmakis I.T.
Fumagalli R.M.
Jing Z.C.
Lee L.H.
McLintock C.
Ní Ainle F.
Giannakoulas G.
Goto S.
Guillermo Esposito M.C.
Jara-Palomares L.
Szlaszynska M.
Tan C.W.
Van Es N.
Wang T.F.
Hunt B.J.
Di Nisio M.
item.page.oairecerif.author.affiliation
Innovations Thérapeutiques en Hémostase
Ramathibodi Hospital
Hospital de Clinicas Dr. Manuel Quintela
Hospital Universitario Virgen del Rocío
Johannes Gutenberg-Universität Mainz
Tokai University School of Medicine
University General Hospital of Thessaloniki "AHEPA"
University of Nigeria
Universitätsmedizin Mainz
Instituto Nacional de Cancerologia, México
UniversitatsSpital Zurich
Singapore General Hospital
University of Ghana
UCD School of Medicine
Auckland City Hospital
Medizinische Universität Wien
The University of Adelaide
Peking Union Medical College Hospital
Tel Aviv University
University of G. d'Annunzio Chieti and Pescara
St Thomas' Hospital
Hopital Louis-Mourier
Harvard Medical School
Universiteit van Amsterdam
Ottawa Hospital Research Institute
Ramathibodi Hospital
Hospital de Clinicas Dr. Manuel Quintela
Hospital Universitario Virgen del Rocío
Johannes Gutenberg-Universität Mainz
Tokai University School of Medicine
University General Hospital of Thessaloniki "AHEPA"
University of Nigeria
Universitätsmedizin Mainz
Instituto Nacional de Cancerologia, México
UniversitatsSpital Zurich
Singapore General Hospital
University of Ghana
UCD School of Medicine
Auckland City Hospital
Medizinische Universität Wien
The University of Adelaide
Peking Union Medical College Hospital
Tel Aviv University
University of G. d'Annunzio Chieti and Pescara
St Thomas' Hospital
Hopital Louis-Mourier
Harvard Medical School
Universiteit van Amsterdam
Ottawa Hospital Research Institute
item.page.dc.contributor.other
item.page.dc.description.abstract
Background: Cancer-associated venous thromboembolism (CAT) has detrimental impact on patients' clinical outcomes and quality of life. Data on CAT education, communication, and awareness among the general cancer population are scanty. Methods: We present the preliminary results of an ongoing patient-centered survey including 27 items covering major spheres of CAT. The survey, available in 14 languages, was promoted and disseminated online through social networks, email newsletters, websites, and media. Results: As of September 20, 2022, 749 participants from 27 countries completed the survey. Overall, 61.8% (n = 460) of responders were not aware of their risk of CAT. Among those who received information on CAT, 26.2% (n = 56) were informed only at the time of CAT diagnosis. Over two thirds (69.1%, n = 501) of participants received no education on signs and symptoms of venous thromboembolism (VTE); among those who were educated about the possible clinical manifestations, 58.9% (n = 119) were given instructions to seek consultation in case of VTE suspicion. Two hundred twenty-four respondents (30.9%) had a chance to discuss the potential use of primary thromboprophylaxis with health-care providers. Just over half (58.7%, n = 309) were unaware of the risks of bleeding associated with anticoagulation, despite being involved in anticoagulant-related discussions or exposed to anticoagulants. Most responders (85%, n = 612) valued receiving CAT education as highly relevant; however, 51.7% (n = 375) expressed concerns about insufficient time spent and clarity of education received. Conclusions: This ongoing survey involving cancer patients with diverse ethnic, cultural, and geographical backgrounds highlights important patient knowledge gaps. These findings warrant urgent interventions to improve education and awareness, and reduce CAT burden.